ScienceDex / Researcher record
Chen, Jianjun
- University of Cincinnati · Anatomy & Cell Biology (NIH department code)
- Chicago State University · Pharmacology (NIH department code)
- Beckman Research Institute/City of Hope (no department on record)
From the FY2017 NIH awards this investigator leads as contact PI. The department is the award's.
FY2017 NIH rank #3,792
- R01 Holder
- Long-Funded
- Translational
- Multi-Institutional
NIH Funding · FY2017
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2008 | $286,661 | 1 | #24,660 |
| 2009 | $286,661 | 1 | #28,495 |
| 2010 | $286,661 | 1 | #29,487 |
| 2011 | $278,061 | 1 | #28,069 |
| 2012 | $278,061 | 1 | #28,128 |
| 2014 | $667,416 | 2 | #11,286 |
| 2015 | $671,301 | 3 | #11,346 |
| 2016 | $663,964 | 2 | #11,747 |
| 2017 | $1,570,373 | 7 | #3,792 |
| 2018 | $1,782,211 | 5 | #3,360 |
| 2019 | $1,317,039 | 3 | #5,727 |
| 2020 | $2,478,063 | 5 | #617 |
| 2021 | $2,472,921 | 5 | #2,385 |
| 2022 | $2,138,000 | 4 | #3,250 |
| 2023 | $2,804,488 | 5 | #2,078 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20081 record
- FY20091 record
- FY20101 record
- FY20111 record
- FY20121 record
- FY20142 records
- FY20153 records
- FY20162 records
- FY2017 · selected7 records
- FY20185 records
- FY20193 records
- FY20205 records
- FY20215 records
- FY20224 records
- FY20235 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Anatomy & Cell Biology
- Pharmacology
FY2017 award records by amount
NIH award records listing Chen, Jianjun as a PI. Multi-PI records show the full award amount for context.
- 1R01CA211614-01R01Contact PITargeting TET1 signaling to treat acute myeloid leukemiaUniversity of Cincinnati · Anatomy & Cell Biology (NIH department code)$430.9Kaward amount
- 1R01CA214965-01R01Contact PIThe role and mechanism of FTO in leukemogenesis and drug responseUniversity of Cincinnati · Anatomy & Cell Biology (NIH department code)$389.9Kaward amount
- 5R01CA182528-05R01Contact PIPotential therapeutic implications of targeting miR-150 in acute myeloid leukemiaUniversity of Cincinnati · Anatomy & Cell Biology (NIH department code)$336.1Kaward amount
- 5R01CA178454-05R01Contact PIThe role and functional mechanism of TET1 in MLL-rearranged leukemiaUniversity of Cincinnati · Anatomy & Cell Biology (NIH department code)$291.7Kaward amount
- 1SC3GM122599-01SC3Contact PISynthesis and biological screening of novel HIF-1α inhibitors for the treatment of breast cancerChicago State University · Pharmacology (NIH department code)$54.8Kaward amount
- 7R01CA178454-06R01Contact PIThe role and functional mechanism of TET1 in MLL-rearranged leukemia$37.1Kaward amount
- 7R01CA214965-02R01Contact PIThe role and mechanism of FTO in leukemogenesis and drug response$29.9Kaward amount
Award organizations
Organizations that administered FY2017 awards listing Chen, Jianjun as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardUniversity of Cincinnati
- 2009$500K Cumulative Funding
- 2009Multi-Institutional ResearchAwards at 3 institutions
- 2011$1M Cumulative Funding
- 2014$2M Cumulative Funding
- 2014R01 Grant Holder
- 2017Entered Top 50% NationallyRanked #3792
- 2017Entered Top 25% NationallyRanked #3792
- 2018$5M Cumulative Funding
- 2020$10M Cumulative Funding
- 2020Entered Top 10% NationallyRanked #617
- 2020Entered Top 5% NationallyRanked #617